As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: December 4, 2012
The Women’s Brain Health Initiative congratulates its Founder Lynn Posluns for receiving a prestigious 2012 Canada’s Most Powerful Women: Top 100 Award in the Champion category.
Marking a decade of celebrating female leaders, the Women’s Executive Network (WXN) revealed the recipients of the 10th annual Canada’s Most Powerful Women: Top 100 Award. Each year, these awards celebrate the professional achievements of women across the country in the private, public and not-for-profit sectors.
“I’m honoured to be recognized alongside such an accomplished group of women,” said Posluns. ” The Women’s Brain Health Initiative has become my passion, so much so that I’ve given up my career to focus all my energy on ensuring the Foundation’s success. The enthusiasm that I’ve received for the work I’m now doing is very encouraging.”
Lynn joins a community of 653 women who have received the Top 100™ Award over the last decade, recognizing the highest achieving female leaders in the private, public and not-for-profit sectors in Canada. Winners are selected based on their strategic vision and leadership, their organization’s financial performance, and their commitment to their communities.
Lynn Posluns is Founder and President of the Women’s Brain Health Initiative, the global foundation raising money for research and education to combat women’s aging brain disorders. While serving as Founder and Chair of Women of Baycrest, Lynn recognized the need to raise awareness and funds beyond Toronto to help women stay brain healthy longer. Lynn’s passion and commitment for the cause now continues on a worldwide basis supporting worthy institutions that want to prevent this impending health and social crisis.
“On behalf of the WXN community of 18,000 women, we congratulate each of this year’s Winners who we honour as part of the 10th year of the Top 100 Awards,” said Pamela Jeffery, Founder, Women’s Executive Network. “This is an extraordinary group of female leaders who join our community, and they truly embody the qualities WXN strives to recognize; they are dynamic, inspiring and engaging leaders blazing new trails for the next generation.”
Co-presented by Scotiabank and KPMG, WXN has awarded an outstanding group of women this year from a variety of industries ranging from corporate executives and entrepreneurs to trailblazers and trendsetters changing the world with their professional contributions. This year, WXN celebrates a decade of the Canada’s Most Powerful Women: Top 100 Awards, paying tribute to the 653 incredible women who have received this honour to date, including 88 of whom who have joined the Top 100 Hall of Fame. The complete list of 2012 Top 100 Award Winners can be found at top100women.ca.
Ms. Posluns will be celebrated on December 5 at the Sheraton Centre Toronto, where the Top 100 Award Winners will lead WXN’s afternoon leadership Summit, appropriately themed “An Afternoon of Inspired Leadership,” offering insight to the more than 400 women in attendance. Award Winners will then be celebrated at the Top 100 Awards 10th annual Gala Dinner that evening. Gala attendees will hear from Laureen Harper, who will present the Public Sector Leaders Award category, as well as from keynote speakers Jeanne Beker, entrepreneur and TV personality, and Bonnie Brooks, Hudson’s Bay Company President and CEO.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.